These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 36847957)
1. Prognostic Impact of C-Reactive Protein-to-Lymphocyte Ratio in Non-small Cell Lung Cancer: A Propensity Score-Matching Analysis. Nagano T; Kinoshita F; Hashinokuchi A; Matsudo K; Watanabe K; Takamori S; Kohno M; Miura N; Shimokawa M; Takenaka T; Yoshizumi T Ann Surg Oncol; 2023 Jun; 30(6):3781-3788. PubMed ID: 36847957 [TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of the C-Reactive Protein/Lymphocyte Ratio in Pancreatic Cancer. Fan Z; Luo G; Gong Y; Xu H; Qian Y; Deng S; Huang Q; Yang C; Cheng H; Jin K; Liu C; Yu X Ann Surg Oncol; 2020 Oct; 27(10):4017-4025. PubMed ID: 32144621 [TBL] [Abstract][Full Text] [Related]
3. The prognostic value of the preoperative albumin/globulin and monocyte ratio in resected early-stage non-small cell lung cancer. Wu W; Zhang L; Wang C; Xu Z; Feng C; Zhang Z; Qin D; Zhang C; Lin F Asian J Surg; 2024 Jan; 47(1):118-123. PubMed ID: 37419798 [TBL] [Abstract][Full Text] [Related]
4. Naples Prognostic Score as a novel prognostic prediction tool in video-assisted thoracoscopic surgery for early-stage lung cancer: a propensity score matching study. Li S; Wang H; Yang Z; Zhao L; Lv W; Du H; Che G; Liu L Surg Endosc; 2021 Jul; 35(7):3679-3697. PubMed ID: 32748268 [TBL] [Abstract][Full Text] [Related]
5. The preoperative C-reactive protein-lymphocyte ratio and the prognosis of oral cavity squamous cell carcinoma. Ko CA; Fang KH; Hsu CM; Lee YC; Chang GH; Huang EI; Tsai MS; Tsai YT Head Neck; 2021 Sep; 43(9):2740-2754. PubMed ID: 33991004 [TBL] [Abstract][Full Text] [Related]
6. Prognostic role and clinical significance of C-reactive protein-lymphocyte ratio in colorectal cancer. Meng Y; Long C; Huang X; Huang L; Liao L; Tang W; Liu J Bioengineered; 2021 Dec; 12(1):5138-5148. PubMed ID: 34436973 [TBL] [Abstract][Full Text] [Related]
7. Preoperative platelet-lymphocyte ratio is a superior prognostic biomarker to other systemic inflammatory response markers in non-small cell lung cancer. Huang Q; Diao P; Li CL; Peng Q; Xie T; Tan Y; Lang JY Medicine (Baltimore); 2020 Jan; 99(4):e18607. PubMed ID: 31977852 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of pre-resection albumin/fibrinogen ratio in patients with non-small cell lung cancer: A propensity score matching analysis. Chen S; Yan H; Du J; Li J; Shen B; Ying H; Zhang Y; Chen S Clin Chim Acta; 2018 Jul; 482():203-208. PubMed ID: 29653085 [TBL] [Abstract][Full Text] [Related]
9. Novel systemic inflammation response index to predict prognosis after thoracoscopic lung cancer surgery: a propensity score-matching study. Li S; Yang Z; Du H; Zhang W; Che G; Liu L ANZ J Surg; 2019 Nov; 89(11):E507-E513. PubMed ID: 31667974 [TBL] [Abstract][Full Text] [Related]
10. Effect of C-reactive protein/albumin ratio on prognosis in advanced non-small-cell lung cancer. Ni XF; Wu J; Ji M; Shao YJ; Xu B; Jiang JT; Wu CP Asia Pac J Clin Oncol; 2018 Dec; 14(6):402-409. PubMed ID: 30178541 [TBL] [Abstract][Full Text] [Related]
11. Development and Validation of an Immune-Based Prognostic Risk Score for Patients With Resected Non-Small Cell Lung Cancer. He L; Huang Y; Chen X; Huang X; Wang H; Zhang Y; Liang C; Li Z; Yan L; Liu Z Front Immunol; 2022; 13():835630. PubMed ID: 35401554 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of postoperative decrease in serum albumin on surgically resected early-stage non-small cell lung carcinoma: A multicenter retrospective study. Kinoshita F; Tagawa T; Yamashita T; Takenaka T; Matsubara T; Toyokawa G; Takada K; Oba T; Osoegawa A; Yamazaki K; Takenoyama M; Shimokawa M; Nakashima N; Mori M PLoS One; 2021; 16(9):e0256894. PubMed ID: 34473762 [TBL] [Abstract][Full Text] [Related]
13. Serum uric acid to lymphocyte ratio: A novel prognostic biomarker for surgically resected early-stage lung cancer. A propensity score matching analysis. Yang Z; Li S; Zhao L; Lv W; Ju J; Zhang W; Li J; Che G Clin Chim Acta; 2020 Apr; 503():35-44. PubMed ID: 31926813 [TBL] [Abstract][Full Text] [Related]
14. The Prognostic Significance of C-reactive Protein-To-Lymphocyte Ratio in Colorectal Liver Metastases. Taniai T; Haruki K; Hamura R; Fujiwara Y; Furukawa K; Gocho T; Shiba H; Yanaga K J Surg Res; 2021 Feb; 258():414-421. PubMed ID: 33109402 [TBL] [Abstract][Full Text] [Related]
15. The combination of plasma fibrinogen and neutrophil lymphocyte ratio (F-NLR) is a predictive factor in patients with resectable non small cell lung cancer. Wang H; Zhao J; Zhang M; Han L; Wang M; Xingde L J Cell Physiol; 2018 May; 233(5):4216-4224. PubMed ID: 29057536 [TBL] [Abstract][Full Text] [Related]
16. Gustave Roussy Immune Score based on a three-category risk assessment scale serves as a novel and effective prognostic indicator for surgically resectable early-stage non-small-cell lung cancer: A propensity score matching retrospective cohort study. Li SJ; Zhao L; Wang HY; Zhou HN; Ju J; Du H; Che GW Int J Surg; 2020 Dec; 84():25-40. PubMed ID: 33086147 [TBL] [Abstract][Full Text] [Related]
17. Controlling Nutritional Status (CONUT) score is a prognostic marker in III-IV NSCLC patients receiving first-line chemotherapy. Zhang Y; Kong FF; Zhu ZQ; Shan HX BMC Cancer; 2023 Mar; 23(1):225. PubMed ID: 36894927 [TBL] [Abstract][Full Text] [Related]
18. A Retrospective Propensity Score Matched Study of the Preoperative C-Reactive Protein to Albumin Ratio and Prognosis in Patients with Resectable Non-Metastatic Breast Cancer. Zhou L; Ma S; Balde AI; Han S; Cai Z; Li Z Med Sci Monit; 2019 Jun; 25():4342-4352. PubMed ID: 31182704 [TBL] [Abstract][Full Text] [Related]
19. Preoperative serum C-reactive protein levels and postoperative survival in patients with esophageal squamous cell carcinoma: a propensity score matching analysis. Huang W; Wu L; Liu X; Long H; Rong T; Ma G J Cardiothorac Surg; 2019 Sep; 14(1):167. PubMed ID: 31533862 [TBL] [Abstract][Full Text] [Related]
20. The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell Lung Cancer Treated with Stereotactic Radiotherapy. Zhang Y; Chen Z; Jin F; Guo D; Chen Q; Liu Z; Ji S; Gao G Mediators Inflamm; 2021; 2021():2910892. PubMed ID: 34744510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]